Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Immunodiagnostic Systems Holdings plc (IDH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011111
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. Its clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. IDS offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. The company offers services such as application training and advice, customized training, qualified customer care centers and regionalised proximity teams. It has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.

Immunodiagnostic Systems Holdings plc (IDH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immunodiagnostic Systems Holdings plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deal Details 10
Partnerships 10
Omega Diagnostics Enters Into Licensing Agreement With Immunodiagnostic Systems 10
Immunodiagnostic Systems Enters Into Distribution Agreement With Beijing Leadman Biochemistry For IDS-iSYS 11
Immunodiagnostic Systems Enters Into Research And Development Agreement With Beijing Leadman Biochemistry 12
Immunodiagnostic Systems Enters Into Co-Development Agreement With Diagnostica Stago 13
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 14
Immunodiagnostic Systems Enters into Licensing Agreement with AnaMar 15
Acquisition 16
Immunodiagnostic Acquires Diametra, Medical Device Company 16
Immunodiagnostic Systems Holdings plc – Key Competitors 17
Immunodiagnostic Systems Holdings plc – Key Employees 18
Immunodiagnostic Systems Holdings plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017 21
Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 28
Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 29
Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 30
Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update 31
Jun 22, 2016: Immunodiagnostic Systems Holdings Announces Financial Results 33
Jun 09, 2016: Immunodiagnostic Systems Holdings provides update on re royalty revenues 36
Corporate Communications 37
Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 37
Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 38
Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 39
Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 40
Other Significant Developments 41
Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Immunodiagnostic Systems Holdings plc, Medical Equipment, Key Facts, 2017 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immunodiagnostic Systems Holdings plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immunodiagnostic Systems Holdings plc, Deals By Market, 2011 to YTD 2017 8
Immunodiagnostic Systems Holdings plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Omega Diagnostics Enters Into Licensing Agreement With Immunodiagnostic Systems 10
Immunodiagnostic Systems Enters Into Distribution Agreement With Beijing Leadman Biochemistry For IDS-iSYS 11
Immunodiagnostic Systems Enters Into Research And Development Agreement With Beijing Leadman Biochemistry 12
Immunodiagnostic Systems Enters Into Co-Development Agreement With Diagnostica Stago 13
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 14
Immunodiagnostic Systems Enters into Licensing Agreement with AnaMar 15
Immunodiagnostic Acquires Diametra, Medical Device Company 16
Immunodiagnostic Systems Holdings plc, Key Competitors 17
Immunodiagnostic Systems Holdings plc, Key Employees 18
Immunodiagnostic Systems Holdings plc, Other Locations 19
Immunodiagnostic Systems Holdings plc, Subsidiaries 19

★海外企業調査レポート[Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Peptron Inc (087010):製薬・医療:M&Aディール及び事業提携情報
    Summary Peptron Inc (Peptron) is a developer and manufacturer of peptide and life science medicines. The company develops SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation. It provides peptide synthesis service, express serv …
  • Genetic Technologies Ltd (GTG):企業の財務・戦略的SWOT分析
    Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Iwatani Corp (8088):企業の財務・戦略的SWOT分析
    Iwatani Corp (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Activision Blizzard Inc (ATVI):企業の財務・戦略的SWOT分析
    Activision Blizzard Inc (ATVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Biocartis Group NV (BCART):企業の製品パイプライン分析
    Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology a …
  • Koninklijke Ahold Delhaize N.V.:企業の戦略・SWOT・財務情報
    Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SKY Network Television Limited (SKT):企業の財務・戦略的SWOT分析
    SKY Network Television Limited (SKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • SunPower Corporation (SPWR):電力:M&Aディール及び事業提携情報
    Summary SunPower Corporation (SunPower), a subsidiary of Total Solar International SAS, is a provider of solar technology and energy services. The company has a presence in solar value chain from cell and panel manufacturing, project development, project finance through engineering, procurement, and …
  • Neurosigma Inc:企業の製品パイプライン分析
    Summary Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. It offers Monarch eTNS System for treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD). The company off …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Currence Holding B.V.:企業の戦略・SWOT・財務分析
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Taiho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group focuses on the development, production and marketing of pharmaceutical products in the fields of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic age …
  • NUERNBERGER Beteiligungs-Aktiengesellschaft:企業の戦略・SWOT・財務情報
    NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary NUERNBERGER Beteiligungs-Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務分析
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lucigen Corp:企業の製品パイプライン分析2018
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • WorleyParsons Limited:企業の戦略・SWOT・財務情報
    WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report Summary WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NxStage Medical Inc (NXTM):企業の製品パイプライン分析2018
    Summary NxStage Medical Inc (NxStage) is a medical technology company that develops, manufactures and markets conventional dialysis machines. The company develops products for the treatment of end-stage renal disease and acute kidney failure. It provides products such as nxstage system one, cartridg …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆